98%
921
2 minutes
20
Purpose: To report visual field loss using static perimetry (SP) and kinetic perimetry (KP) over 4 years in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) study.
Design: Prospective, observational cohort study.
Subjects, Participants, And/or Controls: Participants had USH2A-related rod-cone degeneration, visual acuity ≥20/80, and KP III4e ≥10° at baseline in the study eye. Preserved cohorts with baseline visual fields sufficient to detect progression were identified.
Methods: Participants were examined annually through 4 years. Mixed-effects models were used to estimate the annual, standardized rate, and percentage rates of change.
Main Outcome Measures: SP measures included hill of vision (total: V, central 30°: V, and peripheral: V) and centrally weighted mean sensitivity (MScw). Percentages with 4-year progression exceeding the coefficient of repeatability (CoR) and with change meeting Food and Drug Administration (FDA)-recommended criteria were estimated. KP seeing area (dB-steradian (sr)/degree) for I4e, III4e, and V4e isopters was calculated.
Results: The average decline with SP (95% CI) was 1.94 (1.62, 2.25) dB-sr/y for V, 0.54 (0.45, 0.62) dB-sr/y for V, 1.37 (1.11, 1.63) dB-sr/y for V and 0.56 (0.48, 0.64) dB/y for MS. Average percentage decline per year was 8.6% (7.2, 10.0) for V, 6.4% (5.3, 7.5) for V, 13.6% (10.4, 16.7) for V, and 5.6% (4.7, 6.4) for MS. The standardized rate of change was greatest at -1.35 for MS. Rates were higher in the preserved cohorts. Progression exceeding the CoR was 18% (11, 28) for V, 21% (13, 31) for V, 21% (13, 31) for V and 17% (10, 27) for MS. Progression exceeding an FDA-recommended threshold was 5% (2%, 12%) for all SP points and 45% (35%, 55%) for functional transition points. Average KP annual percentage decline was 13.1% (7.5, 18.5) for I4e, 12.1% (8.1,15.9) for III4e, and 9.2% (6.3,12.0) for V4e.
Conclusions: All quantitative perimetry measures declined over 4 years. Progression was greater than the CoR in a relatively low percentage of eyes (17%-21%); 45% exceeded the FDA-recommended threshold when only functional transition points were considered. Standardized rate of change was greatest for MS. These measures are useful characterizations of vision loss in USH2A-related retinal degeneration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajo.2025.03.039 | DOI Listing |
Invest Ophthalmol Vis Sci
August 2025
University Eye Hospital, Center for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Purpose: To document the time course of visual sensitivity loss in dark-adapted visual fields (DAVF). To explore longitudinal relationships between DAVF measured using two-color dark-adapted chromatic and rod function from electroretinogram (ERG) and full-field stimulus testing in the RUSH2A study.
Methods: Full-field rod mean sensitivity, number of rod loci, maximum sensitivity, DAVF V30 were measured in one eye for DAVF ancillary study participants at the RUSH2A 12-month, 24-month, 36-month and 48-month visits.
Invest Ophthalmol Vis Sci
May 2025
Herbert Wertheim School of Optometry and Vision Science, University of California Berkeley, Berkeley, California, United States.
Purpose: The purpose of this study was to characterize the preferred retinal locus (PRL) structure and fixational eye movements in eyes with macular atrophy.
Methods: Four participants (1 each with macular atrophy due to congenital rubella, Best macular dystrophy, cuticular drusen with macular atrophy, and Stargardt disease) were studied using adaptive optics scanning light ophthalmoscopy (AOSLO), optical coherence tomography (OCT), OCT angiography (OCT-A), and microperimetry. Imaging sessions were repeated in three of the four participants.
Am J Ophthalmol
August 2025
Department of Ophthalmology (S.F., G.J.J., J.L., E.M.L.), Duke University, Durham, North Carolina, USA.
Purpose: To describe the natural history of optical coherence tomography (OCT) and mesopic microperimetry (MP) parameters in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) study.
Design: Multicenter, international, prospective, longitudinal natural history study.
Methods: Study Population: 105 participants with biallelic disease-causing variants in USH2A with a clinical diagnosis of Usher Syndrome or autosomal recessive retinitis pigmentosa who underwent annual testing over 4 years.
Am J Ophthalmol
August 2025
Retina Foundation of the Southwest (M.E.P. and D.G.B.), Dallas, Texas, USA.
Purpose: To report visual field loss using static perimetry (SP) and kinetic perimetry (KP) over 4 years in the Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) study.
Design: Prospective, observational cohort study.
Subjects, Participants, And/or Controls: Participants had USH2A-related rod-cone degeneration, visual acuity ≥20/80, and KP III4e ≥10° at baseline in the study eye.
Purpose: To describe progression of best-corrected visual acuity (BCVA), full-field stimulus thresholds (FST), and electroretinography (ERG) over 4 years in the -related Retinal Degeneration study and to assess their suitability as clinical trial endpoints.
Design: Prospective natural history study.
Participants: Participants (n = 105) with biallelic disease-causing sequence variants in USH2A and BCVA letter scores of ≥54 were included.